Medtronic extends glaucoma line with new aqueous stent
This article was originally published in Clinica
Executive Summary
Medtronic has bought the intellectual property rights to an investigational device for treating glaucoma, the CellPlant Aqueous Stent, from Wound Healing of Oklahoma Inc. Details of the transaction were not disclosed.